生命科学资讯

Illumina launches cloud-based platform for multiomic data analysis - Investing.com

Roche's patent deal with Structure; AstraZeneca reports lupus data

Protagonist 'strongly leaning' toward opting out of Takeda profit-sharing deal

Thermo Fisher Scientific to Present at the J.P. Morgan 2026 Healthcare Conference - BioSpace

Illumina launches powerful software for connected, intuitive, and scalable multiomic analysis - Illumina

Illumina launches powerful software for connected, intuitive, and scalable multiomic analysis - Illumina

Illumina launches powerful software for connected, intuitive, and scalable multiomic analysis - PR Newswire

Bottleneck size drives the evolution of cooperative traits in an aggregative multicellular myxobacterium

A light-entrained clock mechanism in a hydrozoan jellyfish synchronizes evening gamete release

Here's How Much You'd Have If You Invested $1000 in Thermo Fisher Scientific a Decade Ago - Nasdaq

CDC, following Trump’s orders, weakens US stance on childhood vaccinations

Roche Clears Obesity Pill Legal Concerns With Structure Patent Agreement - BioSpace

Lilly goes back to Nimbus for an oral obesity drug in $55M deal

Thermo Fisher Scientific to Present at the J.P. Morgan 2026 Healthcare Conference - Yahoo Finance

PharmaVoice’s Crystal Ball: Market and policy forces shaping the industry

Thermo Fisher Scientific Launches CorEvitas Obesity Registry to Advance Real-World Evidence in Treatment Outcomes - The AI Journal

Thermo Fisher Scientific Launches CorEvitas Obesity Registry to Advance Real-World Evidence in Treatment Outcomes - Business Wire

Arrowhead’s RNAi obesity programs head to Phase 2 after encouraging early data

FDA cites severe liver injury risk, unclear benefit behind Sanofi's MS drug rejection

UK biotech eyes $1B deal to enable eye gene therapy to be delivered in doctors' offices